These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26205467)

  • 1. Assessing drug safety in human tissues - what are the barriers?
    Holmes A; Bonner F; Jones D
    Nat Rev Drug Discov; 2015 Aug; 14(8):585-7. PubMed ID: 26205467
    [No Abstract]   [Full Text] [Related]  

  • 2. New technologies in drug metabolism and toxicity screening: organ-to-organ interaction.
    Bhushan A; Martucci NJ; Usta OB; Yarmush ML
    Expert Opin Drug Metab Toxicol; 2016 May; 12(5):475-7. PubMed ID: 26940609
    [No Abstract]   [Full Text] [Related]  

  • 3. Perspective of humanized mouse models for assessing PK/PD and toxic profile of drug candidates in preclinical study.
    Chiba K
    Drug Metab Pharmacokinet; 2014; 29(1):1-2. PubMed ID: 24573168
    [No Abstract]   [Full Text] [Related]  

  • 4. Navigating the risk landscape.
    Maynard AD
    Nat Nanotechnol; 2016 Mar; 11(3):211-2. PubMed ID: 26936813
    [No Abstract]   [Full Text] [Related]  

  • 5. Consider drug efficacy before first-in-human trials.
    Kimmelman J; Federico C
    Nature; 2017 Jan; 542(7639):25-27. PubMed ID: 28150789
    [No Abstract]   [Full Text] [Related]  

  • 6. Introduction to nonclinical safety pharmacology and the safety pharmacology society.
    Bass AS; Vargas HM; Kinter LB
    J Pharmacol Toxicol Methods; 2004; 49(3):141-4. PubMed ID: 15172009
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugs in control samples in nonclinical safety studies: a reconsideration.
    Zimmer D
    Bioanalysis; 2016 May; 8(10):1003-7. PubMed ID: 27080047
    [No Abstract]   [Full Text] [Related]  

  • 8. Zebrafish based assays for the assessment of cardiac, visual and gut function--potential safety screens for early drug discovery.
    Berghmans S; Butler P; Goldsmith P; Waldron G; Gardner I; Golder Z; Richards FM; Kimber G; Roach A; Alderton W; Fleming A
    J Pharmacol Toxicol Methods; 2008; 58(1):59-68. PubMed ID: 18585469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety immunopharmacology: evaluation of the adverse potential of pharmaceuticals on the immune system.
    Descotes J
    J Pharmacol Toxicol Methods; 2012 Sep; 66(2):79-83. PubMed ID: 22587937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the safety assessment of drug-mediated changes in the QT interval... what's next?
    Pugsley MK; Authier S; Towart R; Gallacher DJ; Curtis MJ
    J Pharmacol Toxicol Methods; 2009; 60(1):24-7. PubMed ID: 19616107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodological innovations expand the safety pharmacology horizon.
    Pugsley MK; Curtis MJ
    J Pharmacol Toxicol Methods; 2012 Sep; 66(2):59-62. PubMed ID: 22617368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug discovery: computer model predicts side effects.
    Kolaja K
    Nature; 2012 Jun; 486(7403):326-7. PubMed ID: 22722185
    [No Abstract]   [Full Text] [Related]  

  • 13. Animal models of human disease in drug safety assessment.
    Boelsterli UA
    J Toxicol Sci; 2003 Aug; 28(3):109-21. PubMed ID: 12974604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the Safety Assessment of Chemicals and Drug Candidates by the Integration of Bioinformatics and Chemoinformatics Data.
    Steger-Hartmann T; Pognan F
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():29-36. PubMed ID: 29316298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The guinea pig in cardiac safety pharmacology.
    Hamlin RL
    J Pharmacol Toxicol Methods; 2007; 55(1):1-2. PubMed ID: 16844389
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in the development and use of human tissue-based techniques for drug toxicity testing.
    Clotworthy M; Archibald K
    Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1155-69. PubMed ID: 23687950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role for microRNAs in drug toxicity and in safety assessment.
    Marrone AK; Beland FA; Pogribny IP
    Expert Opin Drug Metab Toxicol; 2015 Apr; 11(4):601-11. PubMed ID: 25739314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile toxicity: are we asking the right questions?
    Downes N
    Toxicol Pathol; 2012 Jul; 40(5):830-7. PubMed ID: 22407308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tools to investigate and avoid drug-hypersensitivity in drug development.
    Corsini E; Casula M; Tragni E; Galbiati V; Pallardy M
    Expert Opin Drug Discov; 2018 May; 13(5):425-433. PubMed ID: 29405076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the use of zebrafish larvae in visual safety assessment.
    Richards FM; Alderton WK; Kimber GM; Liu Z; Strang I; Redfern WS; Valentin JP; Winter MJ; Hutchinson TH
    J Pharmacol Toxicol Methods; 2008; 58(1):50-8. PubMed ID: 18541443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.